How are drug prices regulated in India? | In Focus podcast

In Focus by The Hindu

05-01-2023 • 32 mins

In mid-December, a government department told the Kerala High Court that Ribociclib, a drug prescribed for a type of breast cancer, did not meet the conditions necessary to issue a compulsory licence. The drug is patented and therefore cannot be made by generic manufacturers but a compulsory licence, if issued by the government would permit a drug to be manufactured and made available at an affordable price. The case involved a woman, now deceased who said that she and her husband had a joint income of ₹74,400 a month, while the drug Ribociclib cost her ₹58,140, making it unaffordable. A study by the Indian Council of Medical Research has found that breast cancer is one of the top cancers in women in India. Drug prices have evoked national interest following the COVID-19 pandemic, which saw widespread reporting of desperate patients turning to the black market for drugs and devices. In September, the Centre released the National List of Essential Medicines -- the list was released after a gap of seven years, and contains 384 drugs. Interestingly, it also has added, for the first time four drugs that are under patents. So what's in and out of the latest list? How are drug prices regulated in India, and how will the inclusion of drugs on the list help? Does India need to do more to make medicines affordable and accessible?

You Might Like

ThePrint
ThePrint
ThePrint
3 Things
3 Things
Express Audio
Daily Dose
Daily Dose
Newslaundry.com
The Morning Brief
The Morning Brief
The Economic Times
The Big Story
The Big Story
The Quint
Gravitas News
Gravitas News
Making Sense of the NEWS
HT Daily News Wrap
HT Daily News Wrap
Hindustan Times - HT Smartcast
Mint Business News
Mint Business News
Mint - HT Smartcast
FT News Briefing
FT News Briefing
Financial Times
All Things Policy
All Things Policy
IVM Podcasts
Why Not Mint Money
Why Not Mint Money
Mint - HT Smartcast